Demand pull is outrunning the plan for one still-small offering, and the company is visibly re-pointing itself at it
The model's full reasoning — Q3 2023 call → NOWe need to determine if management describes an identifiable offering with both: (1) customer response running ahead of what company prepared for, and (2) company responding now by putting more behind it. The offering must be small relative to total business. Scan transcript. Management discusses AEC (Aerospace Composites) and Machine Clothing. Heimbach acquisition. Also mentions LEAP program, 787, CH-53K, space programs. Also mentions "3D woven composites" as technology. Also mentions "Machine Clothing" as main business. Look for any offering where demand exceeds preparation and company is scaling up. For example, LEAP program: revenue up $15M vs prior guidance, but that's just a beat, not necessarily demand ahead of preparation. Also they mention "we stepped up 787 production" - that's a response to demand? But is that an offering? 787 is a program. They say "During the third quarter, we stepped up 787 production." That suggests they are increasing production. But is customer response running ahead? Not explicitly. They mention "growth in smaller programs" but no specifics. Also mention "3D woven composites" as technology positioned for next gen aircraft. But no current uptake described. Heimbach acquisition: they are integrating, but that's an acquisition, not an offering with demand ahead. Look for any phrase like "demand exceeds" or "outpacing" or "more than expected". I see "We now expect full year ASC LEAP revenues to be up approximately $15 million compared to the full year 2022. 2023 LEAP revenues are higher than we had previously guided as we manage production efficiencies on the program." That's about production efficiencies, not demand ahead. Also "we stepped up 787 production" - that could be a response to demand, but is there evidence that demand is ahead of what they prepared? Not stated. Also "The AEC LEAP program generated $45 million of revenue in the third quarter, nearly $5 million higher than the same period last year." That's just growth. No mention of an offering where customer response is running ahead of preparation. The only thing close is maybe the 787 production step-up, but no explicit statement that demand is ahead of plan. Also the company is not described as putting more resources behind a specific small offering. Thus answer NO.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| HCKT | The Hackett Group, Inc. | Q1 2024 | 2024-05-08 | C |
| ROCK | Gibraltar Industries, Inc. | Q1 2024 | 2024-05-01 | B+ |
| GIII | G-III Apparel Group, Ltd. | Q4 2024 | 2024-03-14 | C |
| PRPH | ProPhase Labs, Inc. | Q1 2023 | 2023-05-11 | F |
| SYY | Sysco Corporation | Q1 2023 | 2022-11-01 | C+ |
| GTES | Gates Industrial Corporation plc | Q4 2021 | 2022-02-07 | C+ |
| ESRT | Empire State Realty Trust, Inc. | Q2 2021 | 2021-07-29 | C+ |
HCKT · Q1 2024 → YESThe question is about whether management describes one identifiable offering that's still small, where customer response is ahead of what they prepared for, AND they're responding now by putting more ...YES The transcript describes AI Explorer (the GenAI assessment platform) as a small, early-stage offering (nominal Q1 revenue impact, part of broader GenAI pivot). Management states customer response is exceeding preparation: "over 175 demo meetings with many more scheduled... resulted in a number of new enterprise...
SYY · Q1 2023 → YESThe question is about whether management describes one identifiable offering or initiative that's still a smaller part of the business, where customer response is running ahead of what they prepared f...YES The transcript shows that Sysco Your Way is presented as a smaller, still-developing offering (described as part of the Recipe For Growth pillars, with its scale expected to grow each quarter and currently limited to specific neighborhoods and recent international rollouts like Toronto and Dublin).
PRPH · Q1 2023 → YESThe question asks if management describes one identifiable offering that's still a smaller part of the business, where customer response is running ahead of what they prepared for, AND they're respond...YES The lozenge manufacturing facility is the clearest match. It is explicitly described as “the least interesting business we’re developing” and still a smaller slice of overall results (COVID testing was the dominant revenue driver for the prior two years).